{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:11:50Z","timestamp":1791375110032,"version":"4.3.1"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi221479-4\"><jats:title>Importance<\/jats:title><jats:p>Switzerland\u2019s mandatory health insurance provides universal coverage, but residents can opt for supplementary private insurance for nonessential, nonvital amenities. It is debated whether people with supplementary private insurance receive overtreatment due to financial incentives.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221479-5\"><jats:title>Objective<\/jats:title><jats:p>To assess whether incidence rates of cardiovascular procedures in people with supplementary private insurance are higher than in those with basic insurance only.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221479-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>A population-based weighted cohort comparative effectiveness study, using administrative claims data from Switzerland assessing incidence rates (IRs), was conducted in adults undergoing a nonemergency cardiovascular inpatient procedure from January 1, 2012, to December 31, 2020. Analysis included primary or secondary discharge procedure codes for 1 of the following: percutaneous transluminal coronary angioplasty (PTCA), left atrial appendage (LAA) occlusion, patent foramen ovale (PFO) closure, transcatheter aortic valve replacement (TAVR), mitral valve clip implantation, cardiac pacemaker implantation, and atrial fibrillation\/atrial flutter ablation.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221479-7\"><jats:title>Exposures<\/jats:title><jats:p>Supplementary private health insurance.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221479-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Incidence rates of cardiovascular procedures between insurance groups calculated by negative binomial regression adjusted by inverse probability weights.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221479-9\"><jats:title>Results<\/jats:title><jats:p>Of 590\u202f919 admissions (median age, 68 years; IQR, 57-77 years), 55.5% male, 15.7% non-Swiss nationality), 70.1% had basic insurance only. Independent of insurance status, IR for all cardiovascular procedures steadily increased over the study years. In general, people with supplementary private insurance received cardiovascular procedures more frequently (IR ratio [IRR], 1.11; 99% CI, 1.10-1.11) than people with basic insurance only. There was also an increase for every procedure: PTCA (IRR, 1.12; 99% CI, 1.12-1.13), LAA closure (IRR, 1.15; 99% CI, 1.13-1.16), mitral valve clip implantation (IRR, 1.08; 99% CI, 1.07-1.09), TAVR (IRR, 1.04; 99% CI, 1.03-1.06), PFO closure (IRR, 1.01; 99% CI, 1.00-1.02), pacemaker implantation (IRR, 1.08; 99% CI, 1.07-1.09), and atrial fibrillation\/atrial flutter ablation (IRR, 1.12; 99% CI, 1.11-1.12). Sensitivity analyses, including side procedures, stratification by length of stay, and propensity score matching, suggested robustness of the results.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221479-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This study found an association between supplementary private insurance and a higher likelihood of receiving nonemergency cardiovascular procedures. Whether this higher rate of procedures in people with supplementary private insurance is based on clinical reasoning or due to financial incentives warrants further exploration.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.51965","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T16:05:42Z","timestamp":1674230742000},"page":"e2251965","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of Cardiovascular Procedure Rates in Patients With Supplementary vs Basic Insurance in Switzerland"],"prefix":"10.1001","volume":"6","author":[{"given":"Tristan","family":"Struja","sequence":"first","affiliation":[{"name":"Medical University Clinic, Division of Endocrinology, Diabetes & Metabolism, Kantonsspital Aarau, Aarau, Switzerland"},{"name":"Massachusetts Institute of Technology, Institute for Medical Engineering and Science, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flurina","family":"Suter","sequence":"additional","affiliation":[{"name":"Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Rohrmann","sequence":"additional","affiliation":[{"name":"Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Koch","sequence":"additional","affiliation":[{"name":"Medical University Clinic, Division of Endocrinology, Diabetes & Metabolism, Kantonsspital Aarau, Aarau, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Mueller","sequence":"additional","affiliation":[{"name":"Medical University Clinic, Division of Endocrinology, Diabetes & Metabolism, Kantonsspital Aarau, Aarau, Switzerland"},{"name":"Medical Faculty of the University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Schuetz","sequence":"additional","affiliation":[{"name":"Medical University Clinic, Division of Endocrinology, Diabetes & Metabolism, Kantonsspital Aarau, Aarau, Switzerland"},{"name":"Medical Faculty of the University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kutz","sequence":"additional","affiliation":[{"name":"Medical University Clinic, Division of Endocrinology, Diabetes & Metabolism, Kantonsspital Aarau, Aarau, Switzerland"},{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"key":"zoi221479r2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejim.2021.08.027","article-title":"Popular procedures without evidence of benefit: a case study of percutaneous coronary intervention for stable coronary artery disease.","volume":"94","author":"Guduguntla","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"23","key":"zoi221479r3","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1056\/NEJMp1508256","article-title":"Individual responsibility and community solidarity\u2013the Swiss health care system.","volume":"373","author":"Biller-Andorno","year":"2015","journal-title":"N Engl J Med"},{"key":"zoi221479r6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4414\/cvm.2022.02201","article-title":"The SWISS PCI survey\u2014coronary and structural heart interventions in Switzerland 2020.","volume":"25","author":"Boeddinghaus","year":"2022","journal-title":"Cardiovasc Med"},{"issue":"20","key":"zoi221479r8","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"zoi221479r9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"zoi221479r12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","article-title":"A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data.","volume":"47","author":"van Walraven","year":"2009","journal-title":"Med Care"},{"issue":"6","key":"zoi221479r13","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research.","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"issue":"17","key":"zoi221479r14","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1001\/jama.2017.15927","article-title":"Factors associated with increases in US health care spending, 1996-2013.","volume":"318","author":"Dieleman","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"zoi221479r15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"European Society of Cardiology: cardiovascular disease statistics 2019.","volume":"41","author":"Timmis","year":"2020","journal-title":"Eur Heart J"},{"issue":"19","key":"zoi221479r16","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1001\/jama.2015.13764","article-title":"Appropriate use criteria for coronary revascularization and trends in utilization, patient selection, and appropriateness of percutaneous coronary intervention.","volume":"314","author":"Desai","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"zoi221479r17","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1001\/jamainternmed.2020.3181","article-title":"Potential association of the ISCHEMIA trial with the appropriate use criteria ratings for percutaneous coronary intervention in stable ischemic heart disease.","volume":"180","author":"Malik","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"20","key":"zoi221479r18","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1016\/j.jacc.2017.09.018","article-title":"ACC\/AATS\/AHA\/ASE\/EACTS\/HVS\/SCA\/SCAI\/SCCT\/SCMR\/STS 2017 appropriate use criteria for the treatment of patients with severe aortic stenosis: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.","volume":"70","author":"Bonow","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"zoi221479r19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.119.006146","article-title":"Appropriateness of transcatheter aortic valve replacement: insight from the OCEAN-TAVI Registry.","volume":"13","author":"Inohara","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"zoi221479r20","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1001\/jama.1981.03320070038021","article-title":"Impact of peer review in reduction of permanent pacemaker implantations.","volume":"246","author":"Chokshi","year":"1981","journal-title":"JAMA"},{"key":"zoi221479r21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/med.2017.68.issue-1","article-title":"Cardiac pacing and defibrillation devices: cost and effectiveness.","volume":"68","author":"Groeneveld","year":"2017","journal-title":"Annu Rev Med"},{"issue":"2","key":"zoi221479r22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10840-012-9747-5","article-title":"The pathway to physician reimbursement for cardiac implantable electronic devices (CIEDs): a history and brief synopsis.","volume":"36","author":"Roka","year":"2013","journal-title":"J Interv Card Electrophysiol"},{"issue":"35","key":"zoi221479r23","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","article-title":"2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy.","volume":"42","author":"Glikson","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"zoi221479r24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.001767","article-title":"Standardized outcome measurement for patients with coronary artery disease: consensus from the International Consortium for Health Outcomes Measurement (ICHOM).","volume":"4","author":"McNamara","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"17","key":"zoi221479r25","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.jacc.2017.02.001","article-title":"ACC\/AATS\/AHA\/ASE\/ASNC\/SCAI\/SCCT\/STS 2017 Appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons.","volume":"69","author":"Patel","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"zoi221479r26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11657-016-0302-3","article-title":"Impact of structural and economic factors on hospitalization costs, inpatient mortality, and treatment type of traumatic hip fractures in Switzerland.","volume":"12","author":"Mehra","year":"2017","journal-title":"Arch Osteoporos"},{"issue":"9","key":"zoi221479r27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238287","article-title":"Regional variation in hip and knee arthroplasty rates in Switzerland: a population-based small area analysis.","volume":"15","author":"Wertli","year":"2020","journal-title":"PLoS One"},{"key":"zoi221479r28","doi-asserted-by":"publisher","DOI":"10.4414\/smw","article-title":"Variation in incidence of orthopaedic surgery between populations with basic or basic plus supplementary health insurance in Switzerland.","volume":"141","author":"Busato","year":"2011","journal-title":"Swiss Med Wkly"},{"issue":"5","key":"zoi221479r29","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1080\/17453674.2017.1344915","article-title":"Inappropriate use of arthroscopic meniscal surgery in degenerative knee disease.","volume":"88","author":"Muheim","year":"2017","journal-title":"Acta Orthop"},{"key":"zoi221479r4","first-page":"8","volume-title":"Vergleich der soziodemografischen Merkmale, des Gesundheitszustands und der Inanspruchnahme von Versorgungsleistungen","author":"Roth","year":"2021"},{"key":"zoi221479r10","author":"Sektion Gesundheit der Bev\u00f6lkerung","year":"2022"},{"key":"zoi221479r1","unstructured":"OECD iLibrary. Health at a glance 2021: OECD indicators. 2021. Accessed April 30, 2022. https:\/\/www.oecd-ilibrary.org\/social-issues-migration-health\/health-at-a-glance-2021_ae3016b9-en"},{"key":"zoi221479r5","unstructured":"Engelberger? K. Akutstation\u00e4re Spitaltarife im Zusatzversicherungsbereich Ein nationaler Tarif\u2013und Kostenvergleich. 2021:17. October 2021. Accessed April 30, 2022. https:\/\/www.preisueberwacher.admin.ch"},{"key":"zoi221479r7","unstructured":"OECD.Stat. Health care resources. 2022. Accessed June 25, 2022. https:\/\/stats.oecd.org\/Index.aspx?DataSetCode=HEALTH_REAC"},{"key":"zoi221479r11","unstructured":"Federal Statistical Office. Population. December 2021. Accessed November 18, 2022. https:\/\/www.bfs.admin.ch\/bfs\/en\/home\/statistics\/population\/effectif-change\/population.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2800687\/struja_2023_oi_221479_1673544631.04534.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T16:05:50Z","timestamp":1674230750000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2800687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.51965","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,20]]}}}